Literature DB >> 27679553

Colorectal Cancer and Dysplasia in Inflammatory Bowel Disease: A Review of Disease Epidemiology, Pathophysiology, and Management.

Parambir S Dulai1, William J Sandborn1, Samir Gupta2,3,4.   

Abstract

Crohn disease and ulcerative colitis are chronic inflammatory bowel diseases (IBD) characterized by recurrent episodes of mucosal inflammation. This chronic mucosal inflammation has several potential consequences, one of which is the occurrence of colitis-associated colorectal cancer. Over the past decade, our understanding of the epidemiology, pathophysiology, and overall approach to diagnosing and managing colitis-associated colorectal cancer has grown considerably. In the current review article, we outline these advancements and highlight areas in need of further research. Cancer Prev Res; 9(12); 887-94. ©2016 AACR. ©2016 American Association for Cancer Research.

Entities:  

Mesh:

Year:  2016        PMID: 27679553      PMCID: PMC5289746          DOI: 10.1158/1940-6207.CAPR-16-0124

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  104 in total

1.  White light endoscopy versus chromoendoscopy for the detection of dysplasia during inflammatory bowel disease surveillance with colonoscopy.

Authors:  Haleh Vaziri; Joseph C Anderson
Journal:  Gastroenterology       Date:  2015-10-01       Impact factor: 22.682

2.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

3.  The risk of colorectal cancer in ulcerative colitis: a meta-analysis.

Authors:  J A Eaden; K R Abrams; J F Mayberry
Journal:  Gut       Date:  2001-04       Impact factor: 23.059

4.  Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases.

Authors:  Ashwin N Ananthakrishnan; Andrew Cagan; Tianxi Cai; Vivian S Gainer; Stanley Y Shaw; Susanne Churchill; Elizabeth W Karlson; Shawn N Murphy; Isaac Kohane; Katherine P Liao
Journal:  Clin Gastroenterol Hepatol       Date:  2014-07-17       Impact factor: 11.382

5.  Primary sclerosing cholangitis and ulcerative colitis: evidence for increased neoplastic potential.

Authors:  U Broomé; R Löfberg; B Veress; L S Eriksson
Journal:  Hepatology       Date:  1995-11       Impact factor: 17.425

6.  IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer.

Authors:  Sergei Grivennikov; Eliad Karin; Janos Terzic; Daniel Mucida; Guann-Yi Yu; Sivakumar Vallabhapurapu; Jürgen Scheller; Stefan Rose-John; Hilde Cheroutre; Lars Eckmann; Michael Karin
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

7.  Inhibition of cytokine production by methotrexate. Studies in healthy volunteers and patients with rheumatoid arthritis.

Authors:  A H Gerards; S de Lathouder; E R de Groot; B A C Dijkmans; L A Aarden
Journal:  Rheumatology (Oxford)       Date:  2003-05-30       Impact factor: 7.580

8.  Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis.

Authors:  Boryana K Popivanova; Kazuya Kitamura; Yu Wu; Toshikazu Kondo; Takashi Kagaya; Shiuchi Kaneko; Masanobu Oshima; Chifumi Fujii; Naofumi Mukaida
Journal:  J Clin Invest       Date:  2008-02       Impact factor: 14.808

9.  Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis.

Authors:  Matthew Rutter; Brian Saunders; Kay Wilkinson; Steve Rumbles; Gillian Schofield; Michael Kamm; Christopher Williams; Ashley Price; Ian Talbot; Alastair Forbes
Journal:  Gastroenterology       Date:  2004-02       Impact factor: 22.682

10.  5-Aminosalicylates reduce the risk of colorectal neoplasia in patients with ulcerative colitis: an updated meta-analysis.

Authors:  Li-Na Zhao; Jie-Yao Li; Tao Yu; Guang-Cheng Chen; Yu-Hong Yuan; Qi-Kui Chen
Journal:  PLoS One       Date:  2014-04-07       Impact factor: 3.240

View more
  39 in total

1.  Trends in Colectomies for Colorectal Neoplasms in Ulcerative Colitis: a National Inpatient Sample Database Analysis over Two Decades.

Authors:  Alexander Ni; Mohammed Al-Qahtani; Ebram Salama; Daniel Marinescu; Maria Abou Khalil; Julio Faria; Nancy Morin; Gabriela Ghitulescu; Carol-Ann Vasilevsky; Marylise Boutros
Journal:  J Gastrointest Surg       Date:  2020-06-15       Impact factor: 3.452

Review 2.  Microenvironmental Metabolism Regulates Antitumor Immunity.

Authors:  Verra M Ngwa; Deanna N Edwards; Mary Philip; Jin Chen
Journal:  Cancer Res       Date:  2019-07-30       Impact factor: 12.701

Review 3.  Biomedical potential of mammalian spectraplakin proteins: Progress and prospect.

Authors:  Sarah A King; Han Liu; Xiaoyang Wu
Journal:  Exp Biol Med (Maywood)       Date:  2019-08-09

4.  No Benefit of Concomitant 5-Aminosalicylates in Patients With Ulcerative Colitis Escalated to Biologic Therapy: Pooled Analysis of Individual Participant Data From Clinical Trials.

Authors:  Siddharth Singh; James A Proudfoot; Parambir S Dulai; Vipul Jairath; Mathurin Fumery; Ronghui Xu; Brian G Feagan; William J Sandborn
Journal:  Am J Gastroenterol       Date:  2018-06-21       Impact factor: 10.864

5.  No benefit of continuing vs stopping 5-aminosalicylates in patients with ulcerative colitis escalated to anti-metabolite therapy.

Authors:  Siddharth Singh; Jihoon Kim; Wenhong Zhu; Parambir S Dulai; William J Sandborn; Vipul Jairath
Journal:  Aliment Pharmacol Ther       Date:  2020-06-23       Impact factor: 8.171

6.  Association between inflammatory bowel disease and prostate cancer: A large-scale, prospective, population-based study.

Authors:  Travis J Meyers; Adam B Weiner; Rebecca E Graff; Anuj S Desai; Lauren Folgosa Cooley; William J Catalona; Stephen B Hanauer; Jennifer D Wu; Edward M Schaeffer; Sarki A Abdulkadir; Shilajit D Kundu; John S Witte
Journal:  Int J Cancer       Date:  2020-05-29       Impact factor: 7.396

7.  Inhibition of MK2 suppresses IL-1β, IL-6, and TNF-α-dependent colorectal cancer growth.

Authors:  Anita L Ray; Kiersten L Berggren; Sebastian Restrepo Cruz; Gregory N Gan; Ellen J Beswick
Journal:  Int J Cancer       Date:  2017-12-12       Impact factor: 7.396

8.  AGA Technical Review on the Management of Moderate to Severe Ulcerative Colitis.

Authors:  Siddharth Singh; Jessica R Allegretti; Shazia Mehmood Siddique; Jonathan P Terdiman
Journal:  Gastroenterology       Date:  2020-01-13       Impact factor: 22.682

9.  Inflammation and Colorectal Cancer.

Authors:  Apple G Long; Emma T Lundsmith; Kathryn E Hamilton
Journal:  Curr Colorectal Cancer Rep       Date:  2017-06-17

10.  Predicting Mucosal Proliferation in Ulcerative Colitis by Assessing Mucosal Vascular Pattern Under Narrow Band Imaging Colonoscopy.

Authors:  Tao Guo; Jia-Ming Qian; Ai-Ming Yang; Yue Li; Wei-Xun Zhou
Journal:  Turk J Gastroenterol       Date:  2021-02       Impact factor: 1.852

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.